PMP22 and microphthalmia: The present study demonstrates that the microphthalmia characteristic of FAS is present very early during fetal development, and is highly correlated with molecular markers (e.g., low levels of MBP and PMP22 mRNA and protein, and elevated levels of activated caspase-3) in fetal cell type-specific exosomes.